Cyclosporine, modified 100 MG Oral Capsule — RxCUI 241834
RxNorm drug concept · Semantic clinical drug
RxCUI 241834
Semantic clinical drug · SCD
● Current RxNorm concept 13 FDA products
13 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI241834
Official nameCyclosporine, modified 100 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped13
Package NDCs mapped13
Reported Medicaid activity (SDUD)20,395 prescriptions · 42 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Cyclosporine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Cyclosporine levels in your blood can vary quite a bit, and both too much and too little can cause real problems — too high raises the risk of kidney damage, and too low means the...
- Why do I need blood tests so often while taking cyclosporine?
- No — grapefruit and grapefruit juice are a hard no with cyclosporine. They block a key enzyme in your body that normally clears cyclosporine, which can cause your blood levels to c...
- Can I eat grapefruit while taking cyclosporine?
🕸️ Concept Web — How Cyclosporine, modified 100 MG Oral Capsule Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Cyclosporine, modified 100 MG Oral Capsule
RxCUI 241834 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Cyclosporine
3008IN -
Cyclosporine, modified
236077PIN
-
Cyclosporine
-
Brand names 4
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Atopica
539497BN -
Gengraf
261530BN -
Neoral
202817BN -
Sporimune
2665975BN
-
Atopica
-
Dose forms 25
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Cyclosporine Oral Capsule
371666SCDF -
Cyclosporine, modified Oral Capsule
2645340SCDFP -
Cyclosporine Oral Product
1156189SCDG -
Cyclosporine Pill
1156190SCDG -
Cyclosporine, modified Oral Product
2660112SCDGP -
Cyclosporine, modified Pill
2662711SCDGP -
Cyclosporine Oral Capsule [Atopica]
539499SBDF -
Cyclosporine Oral Capsule [Gengraf]
366173SBDF - +17 more in this family
-
Cyclosporine Oral Capsule
-
Clinical & branded drugs 9
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Cyclosporine, modified 100 MG
334294SCDC -
Cyclosporine, modified 100 MG Oral Capsule [Atopica]
835917SBD -
Cyclosporine, modified 100 MG Oral Capsule [Gengraf]
835835SBD -
Cyclosporine, modified 100 MG Oral Capsule [Neoral]
835911SBD -
Cyclosporine, modified 100 MG Oral Capsule [Sporimune]
2665981SBD -
Cyclosporine, modified 100 MG [Atopica]
835916SBDC -
Cyclosporine, modified 100 MG [Gengraf]
835787SBDC -
Cyclosporine, modified 100 MG [Neoral]
835900SBDC - +1 more in this family
-
Cyclosporine, modified 100 MG
Showing up to 8 concepts per family — 22 of 40 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Cyclosporine, modified 100 MG
SCDC · 334294 -
Cyclosporine Oral Capsule
SCDF · 371666 -
Cyclosporine, modified Oral Capsule
SCDFP · 2645340 -
Cyclosporine Oral Product
SCDG · 1156189 -
Cyclosporine Pill
SCDG · 1156190 -
Cyclosporine, modified Oral Product
SCDGP · 2660112 -
Cyclosporine, modified Pill
SCDGP · 2662711
Brand-Name Concepts
-
Cyclosporine, modified 100 MG Oral Capsule [Gengraf]
SBD · 835835 -
Cyclosporine, modified 100 MG Oral Capsule [Atopica]
SBD · 835917 -
Cyclosporine, modified 100 MG Oral Capsule [Neoral]
SBD · 835911 -
Cyclosporine, modified 100 MG Oral Capsule [Sporimune]
SBD · 2665981 -
Cyclosporine, modified 100 MG [Atopica]
SBDC · 835916 -
Cyclosporine, modified 100 MG [Gengraf]
SBDC · 835787 -
Cyclosporine, modified 100 MG [Neoral]
SBDC · 835900 -
Cyclosporine, modified 100 MG [Sporimune]
SBDC · 2665976 -
Cyclosporine Oral Capsule [Atopica]
SBDF · 539499 -
Cyclosporine Oral Capsule [Gengraf]
SBDF · 366173
📦 FDA Products & Package NDCs
13 products · 13 package NDCs
13 package NDCs map to RxCUI 241834 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00074-3108-32 | 3 BLISTER PACK in 1 CARTON (0074-3108-32) / 10 CAPSULE in 1... | Gengraf | AbbVie Inc. | 2015-11-01 |
| 00074-3109-32 | 5 BLISTER PACK in 1 CARTON (0074-3109-32) / 6 CAPSULE in 1... | Gengraf | AbbVie Inc. | 2015-11-01 |
| 00093-9018-65 | 30 BLISTER PACK in 1 CARTON (0093-9018-65) / 1 CAPSULE, LIQ... | Cyclosporine Modified | Teva Pharmaceuticals USA, Inc. | 2021-06-08 |
| 00093-9019-65 | 30 BLISTER PACK in 1 CARTON (0093-9019-65) / 1 CAPSULE, LIQ... | Cyclosporine Modified | Teva Pharmaceuticals USA, Inc. | 2021-06-08 |
| 00093-9020-65 | 30 BLISTER PACK in 1 CARTON (0093-9020-65) / 1 CAPSULE, LIQ... | Cyclosporine Modified | Teva Pharmaceuticals USA, Inc. | 2021-06-08 |
| 23155-0837-30 | 3 BLISTER PACK in 1 CARTON (23155-837-30) / 10 CAPSULE, LIQ... | CYCLOSPORINE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2022-11-30 |
| 23155-0838-30 | 6 BLISTER PACK in 1 CARTON (23155-838-30) / 5 CAPSULE, LIQU... | CYCLOSPORINE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2022-11-30 |
| 23155-0839-30 | 5 BLISTER PACK in 1 CARTON (23155-839-30) / 6 CAPSULE, LIQU... | CYCLOSPORINE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 2022-11-30 |
| 60505-4630-03 | 30 BLISTER PACK in 1 CARTON (60505-4630-3) / 10 CAPSULE, LI... | CycloSPORINE, Modfied | Apotex Corp. | 2019-11-05 |
| 60505-4631-03 | 30 BLISTER PACK in 1 CARTON (60505-4631-3) / 5 CAPSULE, LIQ... | CycloSPORINE, Modfied | Apotex Corp. | 2019-11-05 |
| 60505-4632-03 | 30 BLISTER PACK in 1 CARTON (60505-4632-3) / 6 CAPSULE, LIQ... | CycloSPORINE, Modfied | Apotex Corp. | 2019-11-05 |
| 75907-0047-30 | 30 BLISTER PACK in 1 BOX (75907-047-30) / 1 CAPSULE, LIQUID... | Cyclosporine | Dr. Reddy's Laboratories Inc | 2024-07-01 |
| 75907-0048-30 | 30 BLISTER PACK in 1 BOX (75907-048-30) / 1 CAPSULE, LIQUID... | Cyclosporine | Dr. Reddy's Laboratories Inc | 2024-07-01 |
Observed labelers:
Apotex Corp. (3) ·
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (3) ·
Teva Pharmaceuticals USA, Inc. (3) ·
AbbVie Inc. (2) ·
Dr. Reddy's Laboratories Inc (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J7502 | Cyclosporine oral 100 mg | 6 | CMS |
| J7515 | Cyclosporine oral 25 mg | 6 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.